30.44
price up icon2.63%   0.78
after-market アフターアワーズ: 29.84 -0.60 -1.97%
loading

Edgewise Therapeutics Inc (EWTX) 最新ニュース

pulisher
Feb 26, 2026

Stifel raises Edgewise Therapeutics stock price target on trial data timeline - Investing.com Canada

Feb 26, 2026
pulisher
Feb 26, 2026

Edgewise Therapeutics, Inc. SEC 10-K Report - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Assessing Edgewise Therapeutics (EWTX) Valuation After Strong Multi‑Year Returns And Recent Share Price Momentum - Yahoo Finance

Feb 26, 2026
pulisher
Feb 26, 2026

Edgewise Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results with Strong Progress Across Muscular Dystrophy and Cardiovascular Programs - PR Newswire

Feb 26, 2026
pulisher
Feb 25, 2026

Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 52-Week HighStill a Buy? - MarketBeat

Feb 25, 2026
pulisher
Feb 25, 2026

Edgewise Therapeutics stock hits 52-week high at $31.39 - Investing.com

Feb 25, 2026
pulisher
Feb 24, 2026

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Target Price Suggests 26.84% Upside for Biotech Innovator - DirectorsTalk Interviews

Feb 24, 2026
pulisher
Feb 24, 2026

How Edgewise Therapeutics Inc. (EWTX) Affects Rotational Strategy Timing - Stock Traders Daily

Feb 24, 2026
pulisher
Feb 23, 2026

Edgewise Therapeutics (EWTX) Projected to Post Earnings on Monday - MarketBeat

Feb 23, 2026
pulisher
Feb 21, 2026

Published on: 2026-02-21 16:05:11 - mfd.ru

Feb 21, 2026
pulisher
Feb 20, 2026

Aberdeen Group plc Has $10.05 Million Holdings in Edgewise Therapeutics, Inc. $EWTX - MarketBeat

Feb 20, 2026
pulisher
Feb 19, 2026

Forecast Cut: Will Edgewise Therapeutics Inc benefit from current market trendsJuly 2025 PostEarnings & Weekly Breakout Watchlists - baoquankhu1.vn

Feb 19, 2026
pulisher
Feb 19, 2026

Aug Summary: Is FLIC on track to beat earningsWeekly Profit Recap & Step-by-Step Trade Execution Guides - baoquankhu1.vn

Feb 19, 2026
pulisher
Feb 18, 2026

Edgewise Therapeutics earnings on deck as pipeline advances By Investing.com - Investing.com South Africa

Feb 18, 2026
pulisher
Feb 18, 2026

Edgewise Therapeutics earnings on deck as pipeline advances - Investing.com Nigeria

Feb 18, 2026
pulisher
Feb 17, 2026

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: A High-Potential Biotech Play with 27% Upside - DirectorsTalk Interviews

Feb 17, 2026
pulisher
Feb 17, 2026

GSA Capital Partners LLP Increases Holdings in Edgewise Therapeutics, Inc. $EWTX - MarketBeat

Feb 17, 2026
pulisher
Feb 15, 2026

Published on: 2026-02-16 03:13:40 - mfd.ru

Feb 15, 2026
pulisher
Feb 15, 2026

Is Edgewise Therapeutics Inc. gaining market shareJuly 2025 Reactions & Community Trade Idea Sharing Platform - mfd.ru

Feb 15, 2026
pulisher
Feb 15, 2026

What is Edgewise Therapeutics Inc.’s book value per share2025 Fundamental Recap & Reliable Entry Point Trade Alerts - mfd.ru

Feb 15, 2026
pulisher
Feb 15, 2026

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Feb 15, 2026
pulisher
Feb 15, 2026

Edgewise Therapeutics (NASDAQ:EWTX) Upgraded at Wall Street Zen - MarketBeat

Feb 15, 2026
pulisher
Feb 14, 2026

Will Edgewise Therapeutics Inc. stock gain from government policies2025 Fundamental Recap & Reliable Entry Point Trade Alerts - mfd.ru

Feb 14, 2026
pulisher
Feb 13, 2026

Edgewise Therapeutics Teases Phase 3 Sevasemten Readout, HCM Data Update at Guggenheim Conference - MarketBeat

Feb 13, 2026
pulisher
Feb 13, 2026

(EWTX) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Feb 13, 2026
pulisher
Feb 12, 2026

Is Edgewise Therapeutics Inc. stock positioned for long term growthJuly 2025 Review & Low Risk High Reward Trade Ideas - mfd.ru

Feb 12, 2026
pulisher
Feb 12, 2026

EWTX: Phase III readouts and new cardiac programs drive momentum, with strong commercial readiness - TradingView

Feb 12, 2026
pulisher
Feb 12, 2026

Can Edgewise Therapeutics Inc. reach all time highs this yearJuly 2025 Rallies & Free Accurate Trade Setup Notifications - mfd.ru

Feb 12, 2026
pulisher
Feb 12, 2026

Assessing Edgewise Therapeutics (EWTX) Valuation After Recent Share Price Momentum - Yahoo Finance

Feb 12, 2026
pulisher
Feb 12, 2026

Edgewise Therapeutics to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 on February 12, 2026 - PR Newswire

Feb 12, 2026
pulisher
Feb 12, 2026

Is Edgewise Therapeutics Inc. subject to activist investor interestJuly 2025 WrapUp & Low Drawdown Trading Techniques - mfd.ru

Feb 12, 2026
pulisher
Feb 11, 2026

Why Edgewise Therapeutics Inc. stock remains on watchlistsSwing Trade & Daily Technical Forecast Reports - mfd.ru

Feb 11, 2026
pulisher
Feb 10, 2026

Piper Sandler Sticks to Their Buy Rating for Edgewise Therapeutics (EWTX) - The Globe and Mail

Feb 10, 2026
pulisher
Feb 10, 2026

Why Edgewise Therapeutics stock crushed the market on Monday - MSN

Feb 10, 2026
pulisher
Feb 10, 2026

Edgewise Therapeutics stock hits 52-week high at $30.26 By Investing.com - Investing.com South Africa

Feb 10, 2026
pulisher
Feb 09, 2026

Analyst Reiterates Bullish Stance on Edgewise Stock - Intellectia AI

Feb 09, 2026
pulisher
Feb 09, 2026

Why Edgewise Therapeutics Stock Crushed the Market on Monday - AOL.com

Feb 09, 2026
pulisher
Feb 09, 2026

Edgewise Therapeutics (NASDAQ:EWTX) Sets New 12-Month HighTime to Buy? - MarketBeat

Feb 09, 2026
pulisher
Feb 09, 2026

Why Edgewise Therapeutics Stock Crushed the Market on Monday - The Motley Fool

Feb 09, 2026
pulisher
Feb 09, 2026

Edgewise Therapeutics stock hits 52-week high at $30.26 - Investing.com Nigeria

Feb 09, 2026
pulisher
Feb 09, 2026

Piper Sandler reiterates Overweight rating on Edgewise Therapeutics stock By Investing.com - Investing.com Canada

Feb 09, 2026
pulisher
Feb 09, 2026

Piper Sandler reiterates Overweight rating on Edgewise Therapeutics stock - Investing.com

Feb 09, 2026
pulisher
Feb 07, 2026

Federated Hermes Inc. Decreases Stock Holdings in Edgewise Therapeutics, Inc. $EWTX - MarketBeat

Feb 07, 2026
pulisher
Feb 07, 2026

Edgewise Therapeutics (NASDAQ:EWTX) Downgraded by Wall Street Zen to Sell - MarketBeat

Feb 07, 2026
pulisher
Feb 05, 2026

Growth Recap: Can Edgewise Therapeutics Inc expand its profit margins2025 Earnings Impact & Weekly Stock Breakout Alerts - baoquankhu1.vn

Feb 05, 2026
pulisher
Feb 05, 2026

Braveheart Bio names Marc Evanchik CSO - The Pharma Letter

Feb 05, 2026
pulisher
Feb 05, 2026

Hot Picks: Biotech rebound turns to rare disease catalysts - BNN Bloomberg

Feb 05, 2026
pulisher
Feb 04, 2026

Why Edgewise Therapeutics Inc. stock remains undervaluedEarnings Recap Report & Reliable Volume Spike Alerts - mfd.ru

Feb 04, 2026
pulisher
Feb 03, 2026

Edgewise Therapeutics (EWTX): Analyst Consensus Reveals A 32% Upside Potential - DirectorsTalk Interviews

Feb 03, 2026
pulisher
Feb 03, 2026

Dow Update: What analysts say about Edgewise Therapeutics Inc stockJuly 2025 Review & AI Enhanced Execution Alerts - baoquankhu1.vn

Feb 03, 2026
$101.27
price up icon 1.18%
$28.94
price up icon 1.58%
$53.57
price up icon 3.60%
$110.23
price up icon 1.31%
$149.33
price down icon 0.45%
biotechnology ONC
$316.99
price down icon 1.67%
大文字化:     |  ボリューム (24 時間):